Loading organizations...
§ Private Profile · Boston, MA, USA
Developing oral small molecule reuptake inhibitors for mental health.
Prexa Pharmaceuticals has raised $7.0M across 1 funding round.
Prexa Pharmaceuticals has raised $7.0M in total across 1 funding round.
Prexa Pharmaceuticals has raised $7.0M in total across 1 funding round.
Prexa Pharmaceuticals's investors include Advent Healthcare Ventures, Shire.
Prexa Pharmaceuticals has raised $7.0M across 1 funding round. Most recently, it raised $7.0M Series B in May 2011.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 11, 2011 | $7M Series B | Advent Healthcare Ventures | Shire | Announced |